Viral prevalence of newly- or previously-tested viruses according to HIV status.

1: Adjusted odds ratio (aOR) adjusted for age, year of sampling, detection of viruses previously-tested and whether received 9-valent pneumococcal conjugate vaccine or placebo.
2: p-value not adjusted.
3: Previously-tested by immunofluorescence assay.
4: Previously-tested by nested PCR.
5: Including viruses previously-tested by immunofluorescence assay (RSV, Influenza A, PIV I–III and adenovirus) and nested-PCR (hMPV).
6: All multiple infections included at least one newly-tested virus except in 2 HIV-uninfected children. Viral co-infections with at least one newly-tested virus in HIV-infected children 118 (22.8%) and in HIV-uninfected children 269 (28.5%).
7: Not adjusted for detection of viruses previously-tested.
8: Single infections with a newly-tested virus no other virus, newly- or previously-tested, was detected.
OR: odds ratio.
hBoV: human bocavirus.
WUPyV: polyomavirus-WU.
KIPyV: polyomavirus-KI.
CoV-NL63: coronavirus NL63.
CoV-HKU1: coronavirus HKU1.
CoV-OC43: coronavirus OC43.
CoV-229E: coronavirus 229E.
hRV: human rhinovirus.
RSV: respiratory syncytial virus.
PIV: parainfluenza viruses.
hMPV: human metapneumovirus.